Liverpool ChiroChem, which is part of both the Deepbridge Technology Growth EIS and Deepbridge Life Sciences EIS portfolios, has announced a new partnership with Molecular Forecaster, which is a leading scientific software and consulting company.
Both companies have announced a pilot project collaboration to discover novel asymmetric small-molecule catalysts for the synthesis of enantiopure drug candidates.
Read more about the partnership, here.
About Liverpool ChiroChem
Liverpool ChrioChem are specialists in chemical building blocks & chiral small molecules. They have developed an innovative production process to manufacture its own proprietary chemical compounds for sale, and therefore is able to provide researchers with small volumes of high value chemicals that are currently of high interest but frequently beyond financial reach of resource-constrained research programmes.
- March 2025 (1)
- February 2025 (1)
- January 2025 (1)
- December 2024 (1)
- November 2024 (1)
- October 2024 (4)
- September 2024 (4)
- August 2024 (4)
- July 2024 (1)
- June 2024 (3)
- May 2024 (2)
- April 2024 (2)
- March 2024 (3)
- February 2024 (8)
- January 2024 (7)
- December 2023 (1)
- November 2023 (7)
- October 2023 (6)